Detailansicht

Wissensnetz

Person

Carsten Herskind (1952-)

Wissenschaftler

Name	Carsten Herskind
Zeit	1952- (Lebensdaten)
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Priv.-Doz. Dr. rer. nat.
Beruf	Wissenschaftler (charakteristischer Beruf)
Variante	C. Herskind
Weitere Angaben	Wissenschaftlicher Mitarbeiter in der Klinik für Strahlentherapie und Radioonkologie der Medizinischen Fakultät Mannheim der Universität Heidelberg, dort zuständig für das Labor für molekulare Strahlenbiologie
Datensatztyp	Person
GND-Nummer	1028380488
Datensatz-ID	1028380488
Beteiligt an alle anzeigen Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma Epigenetic modulation of radiation-induced diacylglycerol kinase alpha expression prevents pro-fibrotic fibroblast response Gene expression profiles reveal extracellular matrix and inflammatory signaling in radiation-induced premature differentiation of human fibroblast in vitro Intracellular delivery of doxorubicin by iron oxide-based nano-constructs increases clonogenic inactivation of ionizing radiation in HeLa cells Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin Targeting the post-irradiation tumor microenvironment in glioblastoma via inhibition of CXCL12 TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT) Biology of high single doses of IORT: RBE, 5 R’s, and other biological aspects MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT) Accelerated Partial Breast Irradiation in Clinical Practice INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Carsten Herskind (1952-)

Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma

Epigenetic modulation of radiation-induced diacylglycerol kinase alpha expression prevents pro-fibrotic fibroblast response

Gene expression profiles reveal extracellular matrix and inflammatory signaling in radiation-induced premature differentiation of human fibroblast in vitro

Intracellular delivery of doxorubicin by iron oxide-based nano-constructs increases clonogenic inactivation of ionizing radiation in HeLa cells

Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients

Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin

Targeting the post-irradiation tumor microenvironment in glioblastoma via inhibition of CXCL12

TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)

Biology of high single doses of IORT: RBE, 5 R’s, and other biological aspects

MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching

Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT)

Accelerated Partial Breast Irradiation in Clinical Practice

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?